Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNA7 | P36544 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14128813 | 1.00 | CHRNA7 (0.33) | CHRNA7 | |
| Dimethylamine SCHEMBL9479681 | 0.89 | — | — | |
| SCHEMBL18157902 | 0.89 | CHRNA7 (0.35) | CHRNA7 | |
| SCHEMBL22404371 | 0.86 | — | — | |
| SCHEMBL840162 | 0.84 | CHRNA7 (0.36) | CHRNA7 | |
| SCHEMBL21959012 | 0.83 | — | — | |
| SCHEMBL20283760 | 0.83 | — | — | |
| Hydrochloric Acid SCHEMBL21568420 | 0.81 | CHRNA7 (0.35) | CHRNA7 | |
| SCHEMBL17206827 | 0.78 | — | — | |
| SCHEMBL21955679 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120040361-A | Oilfield desulfurizing agent and preparation method thereof | 中海油(天津)油田化工有限公司 | 2025-05-27 | — | — | CN | claimed |
| CN-120040361-A | Oilfield desulfurizing agent and preparation method thereof | 中海油(天津)油田化工有限公司 | 2025-05-27 | — | — | CN | disclosed |
| US-11746126-B2 | Bicyclic peptide ligands with detectable moieties and uses thereof | Bicyclerd Limited (GB) | 2023-09-05 | — | — | US | disclosed |
| CN-116444378-A | Synthesis method of N-methyl isopropyl amine | 广东优康精细化工有限公司 | 2023-07-18 | — | — | CN | disclosed |
| US-11692077-B2 | Polymer composition containing a phosphonate flame retardant | CHEMISCHE FABRIK BUDENHEIM KG (DE) | 2023-07-04 | — | — | US | disclosed |
| US-11241473-B2 | Bicyclic peptide ligands and uses thereof | BICYCLETX LIMITED (GB) | 2022-02-08 | — | — | US | disclosed |
| CN-113179590-A | Etching solution, replenishment solution, and method for forming copper wiring | MEC股份有限公司 | 2021-07-27 | — | — | CN | disclosed |
| US-20210147484-A1 | BICYCLIC PEPTIDE LIGANDS AND USES THEREOF | BICYCLETX LIMITED (GB) | 2021-05-20 | — | — | US | disclosed |
| CN-107208279-B | Etching solution, replenishment solution, and method for forming copper wiring | MEC股份有限公司 | 2021-03-26 | — | — | CN | disclosed |
| EP-3484857-B1 | CATALYST FOR CURABLE COMPOSITIONS COMPRISING HEXAHYDROTRIAZIN STRUCTURAL UNITS | SIKA TECH AG (CH) | 2021-03-03 | — | — | EP | disclosed |
| US-9616051-B2 | Drug targets to overcome de novo drug-resistance in multiple myeloma | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (US) | 2017-04-11 | — | — | US | disclosed |
| US-20130281389-A1 | NOVEL DRUG TARGETS TO OVERCOME DE NOVO DRUG-RESISTANCE IN MULTIPLE MYELOMA | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. | 2013-10-24 | — | — | US | disclosed |
| US-20130281389-A1 | NOVEL DRUG TARGETS TO OVERCOME DE NOVO DRUG-RESISTANCE IN MULTIPLE MYELOMA | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. | 2013-10-24 | — | — | US | disclosed |
| US-20130281389-A1 | NOVEL DRUG TARGETS TO OVERCOME DE NOVO DRUG-RESISTANCE IN MULTIPLE MYELOMA | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. | 2013-10-24 | — | — | US | disclosed |
| CN-102070461-A | Synthesis method of N-methyl isopropylamine | ZHEJIANG XINHUA CHEMICAL CO LTD | 2011-05-25 | — | — | CN | disclosed |
| US-20050159599-A1 | Cyclic compound, process for producing the same, and pest control agent | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-07-21 | — | — | US | disclosed |
| EP-1481972-A1 | CYCLIC COMPOUND, PROCESS FOR PRODUCING THE SAME, AND PEST CONTROL AGENT | Sumitomo Chemical Takeda Agro Company, Limited (JP) | 2004-12-01 | — | — | EP | disclosed |
| EP-0162938-B1 | USE OF ISOCYANATE OR ISOTHIOCYANATE POLYMERS FOR MAKING MICROCAPSULES | Schmidt, Joachim, Dr.-Med. (DE) | 1989-11-02 | — | — | EP | disclosed |
| EP-0162938-A1 | Use of isocyanate or isothiocyanate polymers for making microcapsules | Schmidt, Joachim, Dr.-Med. (DE) | 1985-12-04 | — | — | EP | disclosed |
| US-4291151-A | Process for preparing polycarbonate using cyclic di- or triamine catalyst | GENERAL ELECTRIC COMPANY (US) | 1981-09-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11746126-B2 | Bicyclic peptide ligands with detectable moieties and uses thereof | VIP, NGLY1, GRPR | CHRNA7 4678/4885 |
| US-20210147484-A1 | BICYCLIC PEPTIDE LIGANDS AND USES THEREOF | VIP, NGLY1, BID | CHRNA7 4239/4885 |
| US-20130281389-A1 | NOVEL DRUG TARGETS TO OVERCOME DE NOVO DRUG-RESISTANCE IN MULTIPLE MYELOMA | XPO1, XPOT, DDB1 | CHRNA7 3924/4885 |
| US-20050159599-A1 | Cyclic compound, process for producing the same, and pest control agent | CNPY2, CNPY3, HAX1 | CHRNA7 3120/4885 |
| US-11241473-B2 | Bicyclic peptide ligands and uses thereof | VIP, NGLY1, BID | CHRNA7 4239/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.